Stevens R, Nicholson J, Sauer A, Nolter T, Corradini L. Evaluation of the Selective Oral CB2 Agonist CNTX-6016 for the Treatment of Neuropathic Pain: Pharmacokinetic, Efficacy, and Safety Findings from Preclinical Studies [abstract]. Presented at: PAINWeek 2019, Las Vegas, Nevada, September 3-7, 2019.